Keisuke Hieda
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
RIOK2 Promotes Clear Cell Renal Cell Carcinoma Progression Through Cell Cycle Regulation.
Journal: Cancer medicine
Published: June 19, 2026
Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma.
Journal: Scientific reports
Published: March 31, 2026
Impact of surgical start time on clinical outcomes in urologic surgery: a single-center study of major oncologic surgeries and adrenalectomy.
Journal: World journal of urology
Published: March 30, 2026
Comprehensive Genomic Characterization Between Urothelial Carcinoma Subtypes/Divergent Differentiation (S/DD) and Pure Urothelial Carcinoma Using a Large-Scale Japanese Genomic Panel Dataset.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: March 19, 2026
Nectin-4 drives aggressive tumor biology and poor prognosis in renal cell carcinoma.
Journal: Urologic oncology
Published: March 08, 2026
External Validation of Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma in a Japanese Cohort: Evaluation of Predictive Performance.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: March 04, 2026
Impact of the Nadir Androgen Receptor Signaling Inhibitor-Derived Integrative Response Model in Real-World Patients With Metastatic Castration-Sensitive Prostate Cancer.
Journal: The Prostate
Published: February 24, 2026
Urine culture-guided antibiotic prophylaxis reduces febrile pyelonephritis after ureteral stent removal following radical cystectomy.
Journal: World journal of urology
Published: January 09, 2026
Over-expression of Paternally Expressed Gene 10 (PEG10) Is Associated With Poor Prognosis in Upper Tract Urothelial Carcinomas.
Journal: Anticancer research
Published: December 21, 2025
Combining Prostate-Specific Antigen Density With PI-RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion-Targeted Re-Biopsy.
Journal: The Prostate
Published: September 21, 2025
KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Journal: Cancer medicine
Published: August 09, 2025
Last Updated: 09/26/2026